In remarks scheduled today for Chief Technology Officer Robb Fraley at Farm Progress Show in Decatur, Ill., Monsanto Company (NYSE: MON) will
announce that, in light of current demand, the company and its licensing
partners expect to have a supply of Roundup Ready 2 Xtend® soybeans for
up to half of all U.S. soybean acres for the 2018 season, doubling what
is planted this season.

Fraley will emphasize several business milestones today as he addresses
grower groups and media attending the annual Farm Progress Show.

Roundup Ready 2 Xtend® Soybeans

“We are hearing that the overwhelming majority of farmers using
Monsanto’s low-volatility dicamba product, XtendiMax® herbicide with
VaporGrip® technology, this year are experiencing tremendous success. In
states where we sold our dicamba product this season, we have heard some
reports of leaf cupping, which can have many possible causes,” Fraley
says. “In the vast majority of situations, we have identified issues
that are addressable through training and following the label
instructions, and we continue to hear from many farmers that our
training and education efforts helped them use the technology
successfully this season.”

To date, Monsanto has directly worked with nearly 50,000 farmers and
applicators at XtendiMax® herbicide with VaporGrip® technology learning
events across the country and will continue to evolve and tailor
trainings to continue to help growers use this new technology
successfully. Fraley will acknowledge the ongoing discussions about
in-crop use of new dicamba formulations.

“We understand that EPA is working with the states and is evaluating
potential actions to facilitate enhanced training and compliance for
2018. We are communicating with the EPA, which is interested in
achieving national uniformity with dicamba regulation to avoid a state
patchwork,” he says. “I’ve seen first-hand that the Roundup Ready 2
Xtend® soybean crop is developing well and I look forward to partnering
with growers through harvest.”

Fraley will underscore the milestones hit in the initial launch year of
the Roundup Ready Xtend® Crop System, including EPA approval for in-crop use of XtendiMax® herbicide with VaporGrip® technology and for numerous
tank mix partners, including glyphosate, and the availability of more
than 120 Roundup Ready 2 Xtend soybean varieties across all relative
maturity zones, more than ten times the products compared to the Roundup
Ready 2 Yield® soybeans launch.

Monsanto now expects that, together with its partners, it will have
supply for up to roughly half of the U.S. soybean market next year,
following a season where more than 20 million acres were planted, on the
way to a market opportunity of 200-250 million acres globally.

“Based on the great demand we’ve seen, we know farmers are looking
forward to the benefits of the Roundup Ready Xtend Crop System,” he
says. “Growers have been asking for this technology for years, and we’re
excited to be able to provide it again in 2018.”

The Roundup Ready Xtend Crop System is designed to provide farmers with
more consistent, flexible control of weeds, especially tough-to-manage
and glyphosate resistant weeds, and to help maximize crop yield
potential. The system includes Roundup Ready 2 Xtend soybeans, the
industry’s first biotech product with tolerance to dicamba and
glyphosate herbicides, and Bollgard II® XtendFlex®, providing tolerance
to three herbicides, dicamba, glyphosate and glufosinate.

The Climate Corporation

Fraley will also express confidence in the advancement of digital
agriculture tools, as The Climate Corporation publicly announces seven
product advancements in an industry-leading research pipeline of more
than 35 projects, including key advancements in fertility and seed
scripting, as well as corn disease diagnosis. Key enhancements, to be
announced in detail later today, will enable more farmers to experience
the value of the Climate FieldView platform.

“The Climate team has several robust research initiatives underway, and
we continue investing heavily in accelerating the speed of innovation to
bring farmers more advanced insights more quickly,” Fraley notes. “Our
R&D innovation spans our entire organization, including science,
technology, engineering and analytics. By expanding our science-backed,
data-driven analytics capabilities and applying them to our growing
streams of field data, we continue to discover never-before-seen
insights that advance FieldView for farmers.”

For more information and the full news release on Climate FieldView,

NemaStrike Technology

Fraley also predicts that future advances in agriculture may come from
the control of the invisible, as evidenced by the company’s breakthrough
product in nematode control, NemaStrike Technology.
Monsanto now offers NemaStrike Technology by Acceleron®
Seed Applied Solutions as a game-changing solution to control the
invasive nematode problem causing greater than 10 percent yield loss in
corn, soybeans and cotton. As a broad-spectrum nematicide, NemaStrike
Technology is designed to strike in the root zone where nematodes attack
while providing consistent yield protection. This technology stands
apart as a means to protect yield.

“The launch of NemaStrike Technology is exciting because the technology
provides broad-spectrum control of plant parasitic nematodes in corn,
soybeans, and cotton,” Fraley says. “Today, many growers underestimate
the severe impact nematodes have on yield and overall crop health.
NemaStrike Technology addresses this important unmet need.”

For more information on Farm Progress Show conversations and
engagements, follow the conversation on Twitter at @RobbFraley or
@MonsantoCo, #FPS17.

About Monsanto Company

Monsanto is committed to bringing a broad range of solutions to help
nourish our growing world. We produce seeds for fruits, vegetables and
key crops - such as corn, soybeans, and cotton - that help farmers have
better harvests while using water and other important resources more
efficiently. We work to find sustainable solutions for soil health, help
farmers use data to improve farming practices and conserve natural
resources, and provide crop protection products to minimize damage from
pests and disease. Through programs and partnerships, we collaborate
with farmers, researchers, nonprofit organizations, universities and
others to help tackle some of the world’s biggest challenges. To learn
more about Monsanto, our commitments and our more than 20,000 dedicated
employees, please visit
Follow our business on Twitter® at

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are “forward-looking
statements,” such as statements concerning the company’s anticipated
financial results, current and future product performance, regulatory
approvals, business and financial plans and other non-historical facts,
as well as the pending transaction with Bayer Aktiengesellschaft
(“Bayer”). These statements are based on current expectations and
currently available information. However, since these statements are
based on factors that involve risks and uncertainties, the company’s
actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that
could cause or contribute to such differences include, among others:
risks related to the pending transaction between the company and Bayer,
including the risk that the regulatory approvals required for the
transaction may not be obtained on the anticipated terms or time frame
or at all, the risk that the other conditions to the completion of the
transaction may not be satisfied, the risk that disruptions or
uncertainties related to the pending transaction could adversely affect
the company’s business, financial performance and/or relationships with
third parties, and the risk that certain contractual restrictions during
the pendency of the transaction could adversely affect the company’s
ability to pursue business opportunities or strategic transactions;
continued competition in seeds, traits and agricultural chemicals; the
company's exposure to various contingencies, including those related to
intellectual property protection, regulatory compliance and the speed
with which approvals are received, and public understanding and
acceptance of our biotechnology and other agricultural products; the
success of the company's research and development activities; the
outcomes of major lawsuits, including potential litigation related to
the pending transaction with Bayer; developments related to foreign
currencies and economies; fluctuations in commodity prices; compliance
with regulations affecting our manufacturing; the accuracy of the
company's estimates related to distribution inventory levels; the recent
increases in levels of indebtedness, continued availability of capital
and financing and rating agency actions; the company's ability to fund
its short-term financing needs and to obtain payment for the products
that it sells; the effect of weather conditions, natural disasters,
accidents, and security breaches, including cybersecurity incidents, on
the agriculture business or the company's facilities; and other risks
and factors detailed in the company's most recent periodic report to the
SEC. Undue reliance should not be placed on these forward-looking
statements, which are current only as of the date of this release. The
company disclaims any current intention or obligation to update any
forward-looking statements or any of the factors that may affect actual